Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

How to select patients with localised soft tissue sarcoma for neoadjuvant/adjuvant chemotherapy?

Speaker: Silvia Stacchiotti, Italy

In this ESMO How To video, Silvia Stacchiotti details to which sub-groups of patients with localised Soft Tissue Sarcoma neoadjuvant/adjuvant chemotherapy may be proposed. She also discusses criterias to be considered such as risk of death at 10 years, and reviews potential therapies.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.